search
NASDAQ:IKT
USD
2.1
- (-1.4%)
INHIBIKASE THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 18 April 2024 GMT-4
USD 2.100
- (-1.4%)
End of Day: 18 April 2024 GMT-4
Industry: Biotechnology

Quote

Market Cap
-
1M Daily Avg. Vol
-
3Y P/B Range
-
52W Range
-
3Y P/S Range
-
3Y DivYield Range
-

Company Info

more

Inhibikase Therapeutics Inc is a clinical-stage pharmaceutical company developing therapeutics for Parkinson's disease and related disorders. Its multi-therapeutic pipeline focuses on neurodegeneratio...

Key Ratios

more

Income

more

Balance Sheet

more

Cash Flow

more

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices